EGFR and adenocarcinoma: Among all patients with adenocarcinoma, 10% had an epidermal growth factor receptor mutation and 3% had the echinoderm microtubule-associated protein-like 4–anaplastic lymphoma kinase (EML4-ALK) fusion gene.